Cargando…
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
BACKGROUND: After development of hormone-refractory metastatic disease, prostate cancer is incurable. The recent history of chemotherapy has shown that with difficult disease targets, combinatorial therapy frequently offers the best chance of a cure. In this study we have examined the effects of a c...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360086/ https://www.ncbi.nlm.nih.gov/pubmed/16417633 http://dx.doi.org/10.1186/1471-2407-6-15 |